Toll like receptors - A novel markers in immunology;Receptory toll-podobne - Nowe znaczniki w immunologii

Alergia Astma Immunologia

Volumn 11, Issue 1, 2006, Pages 23-28

  Tokarz Deptuła, Beata ^a   Niedźwiedzka, Paulina ^a   Deptuła, Wiesław ^a  

^a UNIVERSITY OF SZCZECIN   (Poland)

Author keywords

Molecular patterns of pathogens PAMP; TLR

Indexed keywords

BIOLOGICAL MARKER; TOLL LIKE RECEPTOR;

ARTICLE; BACTERIAL INFECTION; IMMUNE SYSTEM; IMMUNOLOGY; PROTEIN FUNCTION; PROTEIN STRUCTURE; VIRUS INFECTION;

EID: 33748325844     PISSN: 14273101     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Szczepański MJ, Góralski M, Mozer-Lisewska I i wsp. Rola receptorów Toll-podobnych w odporności. Post. Biol. Kom. 2004; 31: 543-561.
2. Beutler B, Wagner H. Toll-like receptor family members and their ligands. Curr. Topics Microbiol. Immun. 2002; 270: 121-143.
3. Larski Z. Postȩp w badaniach nad odpornościa̧ wrodzona̧. Medycyna Wet. 2002; 58: 651-654.
4. Werkling D, Jungi TW. TOLL-like receptors linking innate and adaptive immune response. Vet. Immun. Immunopath. 2003; 91: 1-12.
5. Beutler B. Innate immunity: an overview. Mol Immun 2004; 40: 845-859.
6. Boehme KW, Compton T. Innate sensing of viruses by Toll-Like Receptors. J. Virol. 2004; 78: 7867-7873.
7. Ehlers S. Adaptive immunity in the absence of innate immune responses? The un-Tolled truth of the silent invaders. Eur J Immunol 2004; 34: 1783-1788.
8. O'Neill LAJ. TLRs: Professor Mechnikov, sit on your hat. Trends Immun. 2004; 25: 687-693.
9. Wagner H. The immunology of the TLRs subfamily. Trends Immun. 2004; 25: 381-386.
10. Medzhitov R, Janeway C. An ancient system of host defense. Curr. Opinion Immun. 1998; 10: 12-15.
11. Sochacka M, Błach-Olszewska Z. Mechanizmy wrodzonej odporności. Post. Hig. Med. Dośw. 2005; 59: 250-258.
12. Sousa CR. Toll-like receptors and dendrite cells for whom the bug tolls. Sem. Immun. 2004; 16: 27-34.
13. Janssens S, Beyaert R. Role of Toll-like receptors in pathogen recognition. Clin. Microbiol. Rev. 2003; 16: 637-646.
14. Beone DL, Turer EE, Lee EG. The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses. Nature Immun. 2004; 5: 1052-1060.
15. Beutler B. Inferences, questions and possibilities in toll-like receptor signalling. Nature, Lond. 2004; 430: 257-263.
16. Beutler B, Hoebe K, Du X i wsp. How we detect microbes and respond to them: the toll-like receptors and their transducers. J Leuk. Biol. 2003; 74: 479-485.
17. Kopp E, Medzhitov R. Recognition of microbial infection by Toll-like receptors. Curr. Opinion Immun. 2003; 15: 396-401.
18. Medzhitov R, Preston-Hurlburt P, Janeway CA. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature, Lond. 1997; 388: 394-397.
19. Hemmi H, Takeuchi, Kawai T. A Toll-like receptors recognizes bacterial DNA. Nature, Lond. 2000; 408: 740-746.
20. Zhang D, Zhang G, Hayden MS i wsp. A Toll-like receptor that prevents infection by uropathogenic bacteria. Science 2004; 303: 1522-1526.
21. Hoebe K. Identification of LPS2 as a key transducer of MyD88 - independent TIR signalling. Nature, Lond. 2003; 424: 743-748.
22. Rozwadowska N, Fiszer D, Kurpisz M. Cytokines acting through Toll-like system in human testis. Proc. Immun. Soc. Europ. John Humphrey's School, Zakopane 2002: 9a, 11.
23. Chan VWF, Mecklenbrauker I, Su I. The molecular mechanism of B cell activation by toll-like receptor protein RP-105. J. Exp. Med. 1998; 188: 93-101.
24. Ma Y, Liu H, Tu-Rapp H i wsp. Fas ligation on macrophages enhances IL-1R1-Toll-like receptor 4 signaling and promotes chronic inflammation. Nature Immun. 2004; 5: 380-387.
25. Lebouder E, Rey-Nores JE, Rushmere NK i wsp. Soluble forms of Toll-like receptor (TLR)2 capable of modulating TLR2 signaling are present in human plasma and breast milk. J. Immun. 2003; 171: 6680-6689.
26. Liew FY, Xu D, Brint EK i wsp. Negative regulation of toll-like receptor-mediated immune responses. Nat. Rev. Immun. 2005; 5: 446-458.
27. Meng G. Antagonistic antibody prevents toll-like receptor 2-driven lethal shock-like syndromes. J. Clin. Invest. 2004; 113: 1473-148.
28. Takeuchi O, Akira S. Genetic approaches to the study of Toll-like receptor function. Microbes Infect. 2002; 4: 887-895.
29. Yoshihiro M, Uenishi H, Kikuma R i wsp. Porcine TLR2 and TLR6: identification and their involvement in Mycoplasma hyopneumoniae infection. J. Interferon Cytokine Res. 2003; 23: 583-590.
30. Martin M, Michalek SM, Katz J. Role of innate immune factors in the adjuvant activity of monophosphore lipid A Infect. Immunity 2003; 71: 2498-250.
31. Orme I. Adaptive immunity to mycobacteria. Curr. Opinion Immun. 2004; 7: 58-61.
32. Zhang Y, Blattman JM, Kennedy NJ i wsp. Regulation of innate and adaptive immune responses by MAP kinase phosphatase 5. Nature, Lond. 2004; 430: 793-797.
33. Schulz O, Diebold SS, Chen M i wsp. Toll-like receptor 3 promotes cross-priming to virus-infected cells. Nature, Lond. 2005; 433: 887-892.
34. Sabroe I, Read RC, Whyte MKB i wsp. Toll-like receptors in health and disease: complex questions remain. J. Immun. 2003; 171: 1630-1635.
35. Lien E, Golenbock DT. Adjuvants and their signaling pathways: beyond TLRs. Nature Immun. 2003; 4: 1162-1165.
36. Gomi K, Kawasaki K, Kawai Y i wsp. Toll-like receptor 4-MD-2 complex mediates the signal transduction induced by flavolipin, an amino acid - containing lipid unique to Flavobacterium meningosepticum. J. Immun. 2002; 168: 2939-2943.
37. Platt J, Riggs BL. The "Adonis Effect": Mayo researchers discover genetic basis in mice for aging with strong bones, low body fat. Http://www.mayoclinic.org/news2004-rst/2384.html
38. Dutz JP. Skin immune responses to peptide and protein antigen are TLR4 independent. Cellular Immun. 2003; 226: 16-121.
39. Reichhart J.M. TLR5 takes aim at bacterial propeller. Nature Immun. 2003; 4: 1159-1164.
40. Lemaitre B. The road to Toll. Nat. Rev. Immun. 2004; 4: 521-527.
41. Diebold SS, Kaisho T, Hemmi H i wsp. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 2004; 303: 1529-1531.
42. Heil F, Hemmi H, Hochrein H i wsp. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 2004; 303: 1526-1529.
43. Han X, Fan Y, Wang S i wsp. Dendritic cells from Chlamydia-infected mice show altered Toll-like receptor expression and play a crucial role in inhibition of allergic responses to ovalbumin. Eur. J. Immunol. 2004; 34: 981-989.
44. Modlin RL. A Toll for DNA Vaccines. Nature, Lond. 2000; 408: 659-660.
45. Leifer CA, Kennedy MN, Mazzoni A i wsp. TLR9 is localized in the endoplasmic reticulum prior to stimulation. J. Immun. 2004; 173: 1179-1183.
46. Verthelyi D, Zeuner RA. Differential signaling by CpG in DCs and B cells: not just TLR9. Trends Immun. 2003; 24: 519-522.
47. Akira S, Takeda K. Toll-like receptor signalling. Immunology 2004; 4: 499-511.
48. Athman R, Philpott D. Innate immunity via Toll-like receptors and Nod proteins. Curr. Opinion Microbiol. 2004; 7: 25-32.
49. Ulevitch RJ. Therapeutics targeting the innate immune system. Nature, Lond. 2004; 4: 512-520.
50. Bird L. A new ligand for TLR11. Nat. Rev. Immun. 2005; 5: 432.
51. Zarember KA, Godowski PJ. Tissue expression of human toll-like receptors and differential regulation of toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines. J. Immun. 2002; 168: 554-561.
52. Kumaraguru U, Pack CD, Rouse BT. Toll-like receptor ligand links innate and adaptive immune responses by the production of heat-shock proteins. J. Leuk. Biol. 2003; 73: 574-583.
53. Kang T-J, Chae G-T. Detection of Toll-like receptor 2 TLR2 mutation in the lepromatous leprosy patients. Immun. Med. Microbiol. 2001; 31: 53-58.
54. Koedel U, Angele B, Rupprecht T i wsp. Toll-like receptor 2 participates in mediation of immune response in experimental pneumococcal meningitis. J. Immun. 2003; 170: 438-444.
55. O'Neill LAJ. How NOD-ing off leads to Crohn disease. Nature Immun. 2004; 8: 776-778.